Clinical Trial Update: A Study to Evaluate the Effect of the Experimental GLP-1 Drug PF-07081532 on Blood Levels of Common Birth Control Pills, and Drugs Omeprazole and Midazolam, and Effect of GLP-1 Drug Semaglutide on Midazolam Blood Levels in Healthy Adults With Weight in the Obesity Range [Phase 1]

View source ↗

Summary

Pfizer conducted a Phase 1 study to evaluate how the experimental GLP-1 drug PF-07081532 affects blood levels of common birth control pills, and drugs omeprazol…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• Midazolam (Midazolam)
• Omeprazole (Omeprazole)
• Oral contraceptives (combined oral contraceptives)
• PF-07081532
• semaglutide (semaglutide)

Snippet

Sponsor: Pfizer | Conditions: Obesity | Phase 1 | Status: TERMINATED | Results posted: 2024-12-16